UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
MEDBOOK WORLD, INC.
(Name of Issuer)
Common Shares with a par value of $0.0001
(Title of Class of Securities)
58405B 10 4
(CUSIP Number)
Daniel Masters
1150 Silverado, Ste. 204
La Jolla, CA 92037
(858) 459-1133
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
March 1, 2010
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), (f) or (g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D
- --------------------- -----------------
CUSIP NO. 58405B 10 4 Page 2 of 4 Pages
- --------------------- -----------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Daniel C. Masters
-------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) [ ]
-------------------------------------------------------------------------
6 CITZENSHIP OR PLACE OF ORGANIZATION
United States of America
-------------------------------------------------------------------------
7 SOLE VOTING POWER
10,045,000 Common shares.
NUMBER OF --------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY n/a
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 10,045,000 Common shares.
PERSON --------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
n/a
--------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,045,000 Common shares.
-------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
90.1%
-------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------------
SCHEDULE 13D
- --------------------- -----------------
CUSIP NO. 58405B 10 4 Page 3 of 4 Pages
- --------------------- -----------------
ITEM 1. SECURITY AND ISSUER
This Statement relates to common shares with a par value of $0.0001 of MedBook
World, Inc. (the "Issuer"). The principal executive offices of the Issuer are
located at 1150 Silverado, Suite 204, La Jolla, CA 92037.
ITEM 2. IDENTITY AND BACKGROUND
(a) Daniel C. Masters
(b) 1150 Silverado, Suite 204, La Jolla, CA 92037
(c) Mr. Masters is an attorney. Mr. Masters was elected Director and Chief
Executive Officer on March 1, 2010.
(d) Mr. Masters has not been convicted in any criminal proceeding
(excluding traffic violations or similar misdemeanors) during the last
five years.
(e) Mr. Masters has not been a party to any civil proceeding of a judicial
or administrative body of competent jurisdiction where, as a result of
such proceeding, there was or is a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation
with respect to such laws
(f) Mr. Masters is a citizen of the United States of America.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATIONS
Mr. Masters used his personal funds to acquire the shares.
ITEM 4. PURPOSE OF TRANSACTION
The purpose of the transaction described above was for investment purposes.
Depending on market conditions and other factors, Mr. Masters may acquire
additional shares of the Issuer's common stock as he deems appropriate, whether
in open market purchases, privately negotiated transactions or otherwise. Mr.
Masters also reserves the right to dispose of some or all of the Shares in the
open market, in privately negotiated transactions to third parties or otherwise.
As of the date hereof, Mr. Masters is seeking a merger or acquisition partner
which could result in a transaction under Item 4 (a), (b), (d) or (g) of
Schedule 13D. No such merger or acquisition partner has been identified as of
the date hereof.
SCHEDULE 13D
- --------------------- -----------------
CUSIP NO. 58405B 10 4 Page 4 of 4 Pages
- --------------------- -----------------
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) The aggregate number and percentage of shares of Common Stock to which
this Schedule 13D relates is 10,045,000 shares of Common Stock (which
represents 90.1% of 11,150,000 shares of Common Stock issued and
outstanding as of February 28, 2010).
(b) Mr. Masters has the sole power to vote or direct the vote, and to
dispose or direct the disposition, of 10,045,000 common shares of the
Issuer.
(c) Other than as described in Item 3 above, Mr. Masters has not effected
any transaction in the shares of common stock of the Issuer in the
past sixty days.
(d) N/A
(e) N/A
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Except as set forth above or set forth in the exhibits, there are no contracts,
arrangements, understandings or relationships between Reporting Persons and any
other person with respect to any securities of the Issuer.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
March 2, 2010
- --------------------------------
Dated
/s/ Daniel C. Masters
- --------------------------------
Signature
Daniel C. Masters
- --------------------------------
Name/Title